Literature DB >> 10706138

Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.

J T Richtsmeier1, L L Baxter, R H Reeves.   

Abstract

Mouse genetic models can be used to dissect molecular mechanisms that result in human disease. This approach requires detection and demonstration of compelling parallels between phenotypes in mouse and human. Ts65Dn mice are at dosage imbalance for many of the same genes duplicated in trisomy 21 or Down syndrome (DS), the most common live-born human aneuploidy. Analysis of the craniofacial skeleton of Ts65Dn mice using three-dimensional morphometric methods demonstrates an absolute correspondence between Ts65Dn and DS craniofacial dysmorphology, a distinctive and completely penetrant DS phenotype. The genes at dosage imbalance in Ts65Dn are localized to a small region of mouse chromosome 16 and, by comparative mapping, to the corresponding region of human Chromosome 21, providing independent experimental data supporting the contribution of genes in this region to this characteristic DS phenotype. This analysis establishes precise parallels in human and mouse skull phenotypes resulting from dosage imbalance for the same genes, revealing strong conservation of the evolved developmental genetic program that underlies mammalian skull morphology and validating the use of this mouse model in the analysis of this important DS phenotype. This evolutionary conservation further establishes the mouse as a valid model for a wide range of syndromes producing craniofacial maldevelopment.

Entities:  

Mesh:

Year:  2000        PMID: 10706138     DOI: 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  96 in total

1.  2001 William Allan Award Address. From Down syndrome to the "human" in "human genetics".

Authors:  Charles J Epstein
Journal:  Am J Hum Genet       Date:  2001-12-26       Impact factor: 11.025

2.  Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.

Authors:  Robert Lyle; Corinne Gehrig; Charlotte Neergaard-Henrichsen; Samuel Deutsch; Stylianos E Antonarakis
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

3.  Working memory in the aged Ts65Dn mouse, a model for Down syndrome.

Authors:  Katharine N Whitney; Galen R Wenger
Journal:  Behav Brain Res       Date:  2012-04-04       Impact factor: 3.332

4.  Ohnologs in the human genome are dosage balanced and frequently associated with disease.

Authors:  Takashi Makino; Aoife McLysaght
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

5.  Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice.

Authors:  Randall J Roper; Laura L Baxter; Nidhi G Saran; Donna K Klinedinst; Philip A Beachy; Roger H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

6.  Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

Authors:  Joshua D Blazek; Anna Gaddy; Rachel Meyer; Randall J Roper; Jiliang Li
Journal:  Bone       Date:  2010-09-24       Impact factor: 4.398

7.  A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog.

Authors:  Randall J Roper; Justin F VanHorn; Colyn C Cain; Roger H Reeves
Journal:  Mech Dev       Date:  2008-11-21       Impact factor: 1.882

Review 8.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

9.  Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike.

Authors:  Jiong Yan; Weimin Bi; James R Lupski
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

10.  Episodic-like memory in Ts65Dn, a mouse model of Down syndrome.

Authors:  Fabian Fernandez; Craig C Garner
Journal:  Behav Brain Res       Date:  2007-09-19       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.